Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 1
1999 1
2000 2
2001 1
2002 2
2003 4
2004 1
2005 2
2006 1
2007 2
2008 2
2009 6
2010 3
2011 4
2012 5
2013 4
2014 2
2015 12
2016 7
2017 1
2018 2
2019 1
2020 1
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (Part 3 - Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays).
Corsaro B, Yang TY, Murphy R, Sonderegger I, Exley A, Bertholet S, Dakappagari N, Dessy F, Garofolo F, Kierstead L, Koch H, Sarikonda G, Savoie N, Siggers R, Solstad T, Lu Y, Milton M, Marshall JC, DelCarpini J, Gorovits B, Gupta S, Jesaitis L, Kamerud J, Kromminga A, Ma A, McNally J, Yan H, Wu B, Verthelyi D, Kirshner S, Pedras-Vasconcelos J, Rajadhyaksha M, Staack RF, Cherry E, Cludts I, Dahlbäck M, Gunn GR, Ishii-Watabe A, Jawa V, Kubiak R, Partridge M, Petrillo M, Pine SO, Poetzl J, Song S, Stebbins C, Wu Y, Zhang L, Kar S, Liang M, Abhari MR, Schweighardt B, Stubenrauch K, Xu Y. Corsaro B, et al. Among authors: bertholet s. Bioanalysis. 2021 Mar;13(6):415-463. doi: 10.4155/bio-2021-0007. Epub 2021 Feb 3. Bioanalysis. 2021. PMID: 33533276 Free article.
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models.
Maruggi G, Mallett CP, Westerbeck JW, Chen T, Lofano G, Friedrich K, Qu L, Sun JT, McAuliffe J, Kanitkar A, Arrildt KT, Wang KF, McBee I, McCoy D, Terry R, Rowles A, Abrahim MA, Ringenberg MA, Gains MJ, Spickler C, Xie X, Zou J, Shi PY, Dutt T, Henao-Tamayo M, Ragan I, Bowen RA, Johnson R, Nuti S, Luisi K, Ulmer JB, Steff AM, Jalah R, Bertholet S, Stokes AH, Yu D. Maruggi G, et al. Among authors: bertholet s. Mol Ther. 2022 May 4;30(5):1897-1912. doi: 10.1016/j.ymthe.2022.01.001. Epub 2022 Jan 3. Mol Ther. 2022. PMID: 34990810 Free PMC article. Clinical Trial.
B Cells and Functional Antibody Responses to Combat Influenza.
Lofano G, Kumar A, Finco O, Del Giudice G, Bertholet S. Lofano G, et al. Among authors: bertholet s. Front Immunol. 2015 Jun 30;6:336. doi: 10.3389/fimmu.2015.00336. eCollection 2015. Front Immunol. 2015. PMID: 26175732 Free PMC article. Review.
New horizons in adjuvants for vaccine development.
Reed SG, Bertholet S, Coler RN, Friede M. Reed SG, et al. Among authors: bertholet s. Trends Immunol. 2009 Jan;30(1):23-32. doi: 10.1016/j.it.2008.09.006. Epub 2008 Dec 6. Trends Immunol. 2009. PMID: 19059004 Review.
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.
Maisonneuve C, Bertholet S, Philpott DJ, De Gregorio E. Maisonneuve C, et al. Among authors: bertholet s. Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12294-9. doi: 10.1073/pnas.1400478111. Epub 2014 Aug 18. Proc Natl Acad Sci U S A. 2014. PMID: 25136133 Free PMC article. Review.
69 results